AstraZeneca Reports - Industry Research
Reports Featuring AstraZeneca
Global Pancreatic Cancer Therapeutics and Diagnostics Market
The Global Pancreatic Cancer Therapeutics and Diagnostics Market size is estimated at USD 4.56 billion in 2024, and is expected to reach USD 6.55 billion by 2029, growing at a CAGR of 7.52% during the forecast period (2024-2029).
Middle East And Africa Glucagon-like Peptide-1 (GLP-1) Agonists Market
The Middle East And Africa Glucagon-like Peptide-1 Agonists Market size is estimated at USD 124.32 million in 2024, and is expected to reach USD 175.28 million by 2029, growing at a CAGR of 7.26% during the forecast period (2024-2029).
Middle East and Africa Diabetes Drugs Market
The Middle East and Africa Diabetes Drugs Market size is estimated at USD 4.57 billion in 2023 and is expected to reach USD 6.10 billion by 2028, growing at a CAGR of 5.97% during the forecast period (2023-2028).
Global Pediatric Vaccines Market
The Global Pediatric Vaccines Market size is estimated at USD 20.29 billion in 2024, and is expected to reach USD 27.60 billion by 2029, growing at a CAGR of 6.34% during the forecast period (2024-2029).
Global Cancer Therapy Market
The Global Cancer Therapy Market size is estimated at USD 220.24 billion in 2024, and is expected to reach USD 409.68 billion by 2029, growing at a CAGR of 10.64% during the forecast period (2024-2029).
Cancer Immunotherapy Market
The cancer immunotherapy market is projected to register a CAGR of 9.1% during the forecast period of 2022-2027.
Peptide Therapeutics Market
The peptide therapeutics market is expected to register a CAGR of 9.66% over the forecast period.
Australia Pharmaceuticals Market
Australia Pharmaceuticals Market is likely to register a CAGR of 3% over the forecast period.
Antibody-drug Conjugates Market
The Antibody-drug Conjugates Market size is estimated at USD 12.05 billion in 2024, and is expected to reach USD 44.05 billion by 2029, growing at a CAGR of 29.57% during the forecast period (2024-2029).
Solid Tumor Therapeutics Market
The Solid Tumor Therapeutics Market is expected to register a CAGR of 12.5% during the forecast period.
Middle East & Africa Ovarian Cancer Diagnostics And Therapeutics Market
The Middle East & Africa Ovarian Cancer Diagnostics And Therapeutics Market size is estimated at USD 244.60 million in 2024, and is expected to reach USD 357.73 million by 2029, growing at a CAGR of 7.90% during the forecast period (2024-2029).
Proton Pump Inhibitors Market
The proton pump inhibitors market is poised to grow at a CAGR of 4.5% during the forecast period of the study.
Alzheimer's Disease Diagnostics and Therapeutics Market
The Alzheimer's Disease Diagnostics and Therapeutics Market size is estimated at USD 7.65 billion in 2024, and is expected to reach USD 9.78 billion by 2029, growing at a CAGR of 5.06% during the forecast period (2024-2029).
Asia-Pacific Cancer Vaccines Market
The Asia-Pacific Cancer Vaccines Market size is estimated at USD 2.34 billion in 2024, and is expected to reach USD 4.06 billion by 2029, growing at a CAGR of 11.55% during the forecast period (2024-2029).
North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
The North America Dipeptide Peptidase 4 Inhibitors Market size is estimated at USD 4.02 billion in 2024, and is expected to reach USD 4.20 billion by 2029, growing at a CAGR of 0.9% during the forecast period (2024-2029).
Middle East And Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
The Middle East And Africa Dipeptide Peptidase 4 Inhibitors Market size is estimated at USD 758.32 million in 2024, and is expected to reach USD 893.21 million by 2029, growing at a CAGR of 3.60% during the forecast period (2024-2029).
Sodium-dependent Glucose Co-transporter 2 (SGLT 2) Market
The Sodium-dependent Glucose Co-transporter 2 Market size is estimated at USD 11.42 billion in 2024, and is expected to reach USD 17.32 billion by 2029, growing at a CAGR of 8.68% during the forecast period (2024-2029).
Belgium Pharmaceutical Market
The Belgium pharmaceutical market is anticipated to register growth with a CAGR of 4.35% over the forecast period (2022 - 2027).
Pharmaceutical Manufacturing Market
The Pharmaceutical Manufacturing Market size is estimated at USD 465.16 billion in 2024, and is expected to reach USD 967.12 billion by 2029, growing at a CAGR of 12.14% during the forecast period (2024-2029).
US Diabetes Care Drugs Market
The US Diabetes Care Drugs Market size is estimated at USD 32.59 billion in 2024, and is expected to reach USD 39.08 billion by 2029, growing at a CAGR of 3.70% during the forecast period (2024-2029).
Thailand Diabetes Care Drugs Market
The Thailand Diabetes Care Drugs Market size is estimated at USD 152.23 million in 2024, and is expected to reach USD 173.23 million by 2029, growing at a CAGR of 3.80% during the forecast period (2024-2029).
Philippines Diabetes Care Drugs Market
The Philippines Diabetes Care Drugs Market size is estimated at USD 264.24 million in 2024, and is expected to reach USD 319.95 million by 2029, growing at a CAGR of 3.9% during the forecast period (2024-2029).
South Korea Diabetes Drugs Market
The South Korea Diabetes Drugs Market size is estimated at USD 1 billion in 2024, and is expected to reach USD 1.22 billion by 2029, growing at a CAGR of 4.04% during the forecast period (2024-2029).
Iran Diabetes Care Drugs Market
The Iran Diabetes Care Drugs Market size is estimated at USD 331.92 million in 2024, and is expected to reach USD 401.90 million by 2029, growing at a CAGR of 3.9% during the forecast period (2024-2029).
Japan Diabetes Drugs Market
The Japan Diabetes Drugs Market size is estimated at USD 3.15 billion in 2024, and is expected to reach USD 4.03 billion by 2029, growing at a CAGR of 4.98% during the forecast period (2024-2029).
Japan Oral Anti-Diabetic Drug Market
The Japan Oral Anti-Diabetic Drug Market size is estimated at USD 2.42 billion in 2024, and is expected to reach USD 3.02 billion by 2029, growing at a CAGR of 4.60% during the forecast period (2024-2029).
Italy Oral Anti-Diabetic Drug Market
The Italy Oral Anti-Diabetic Drug Market size is estimated at USD 705.48 million in 2024, and is expected to reach USD 837.88 million by 2029, growing at a CAGR of 3.5% during the forecast period (2024-2029).
India Oral Anti-Diabetic Drug Market
The India Oral Anti-Diabetic Drug Market size is estimated at USD 1.7 billion in 2024, and is expected to reach USD 2.01 billion by 2029, growing at a CAGR of 3.5% during the forecast period (2024-2029).
New Zealand Oral Anti-Diabetic Drug Market
The New Zealand Oral Anti-Diabetic Drug Market size is estimated at USD 323 million in 2024, and is expected to reach USD 367.23 million by 2029, growing at a CAGR of 2.60% during the forecast period (2024-2029).
North America Oral Anti-Diabetic Drug Market
The North America Oral Anti-Diabetic Drug Market size is estimated at USD 18.76 billion in 2024, and is expected to reach USD 23.60 billion by 2029, growing at a CAGR of 4.70% during the forecast period (2024-2029).
Europe Oral Anti-Diabetic Drug Market
The Europe Oral Anti-Diabetic Drug Market size is estimated at USD 7.36 billion in 2024, and is expected to reach USD 8.70 billion by 2029, growing at a CAGR of 3.40% during the forecast period (2024-2029).
Asia-Pacific Oral Anti-Diabetic Drug Market
The Asia-Pacific Oral Anti-Diabetic Drug Market size is estimated at USD 25.37 billion in 2024, and is expected to reach USD 29.56 billion by 2029, growing at a CAGR of 3.10% during the forecast period (2024-2029).
Mexico Oral Anti-Diabetic Drug Market
Mexico's Oral Anti-Diabetic Drug Market is expected to register a CAGR of more than 3% during the forecast period, with revenue of USD 1.5 billion in the current year.
Brazil Oral Anti-Diabetic Drug Market
The Brazil Oral Anti-Diabetic Drug Market is expected to register a CAGR of more than 4% during the forecast period, with revenue of USD 861 million in the current year.
Malaysia Oral Anti-Diabetic Drug Market
The Malaysia Oral Anti-Diabetic Drug Market is expected to register a CAGR of over 3% during the forecast period.
South Korea Oral Anti-Diabetic Drug Market
South Korea Oral Anti-Diabetic Drug Market is expected to register a CAGR of more than 3% during the forecast period and 506 million in revenue in the forecast period.
France Oral Anti-Diabetic Drug Market
France's Oral Anti-Diabetic Drug Market is expected to register a CAGR of more than 4% during the forecast period and revenue of USD 0.7 billion in the current year.
Vietnam Oral Anti-Diabetic Drug Market
The Vietnam Oral Anti-Diabetic Drug Market size is estimated at USD 156.21 million in 2024, and is expected to reach USD 195.32 million by 2029, growing at a CAGR of greater than 4% during the forecast period (2024-2029).
Indonesia Oral Anti-Diabetic Drug Market
The Indonesia Oral Anti-Diabetic Drug Market is expected to register a CAGR of more than 4% during the forecast period and USD 202 million in revenue in the current year.
Philippines Oral Anti-Diabetic Drug Market
The Philippines Oral Anti-Diabetic Drug Market size is estimated at USD 202.20 million in 2024, and is expected to reach USD 251.32 million by 2029, growing at a CAGR of greater than 4% during the forecast period (2024-2029).
Brazil Oral Anti-Diabetic Drug Market
The Brazil Oral Anti-Diabetic Drug Market is expected to register a CAGR of more than 3% during the forecast period, with revenue of USD 13 billion in the current year.
Thailand Oral Antidiabetic Drug Market
Thailand's Oral Anti-Diabetic Drug Market is expected to register a CAGR of more than 6% during the forecast period and 68 million in revenue in the current year.
South Africa Oral Antidiabetic Drug Market
The South Africa Oral Antidiabetic Drug Market size is estimated at USD 241.78 million in 2024, and is expected to reach USD 275.36 million by 2029, growing at a CAGR of greater than 2% during the forecast period (2024-2029).
Dextromethorphan Market
The dextromethorphan market is expected to register a CAGR of 4.1% over the forecast period.
Polypill Products Market
The Polypill Products Market size is estimated at USD 32.80 billion in 2024, and is expected to reach USD 36.20 billion by 2029, growing at a CAGR of 2% during the forecast period (2024-2029).
Antidepressant Market
The antidepressant market is expected to register a CAGR of 3.5% over the forecast period.
Lung Cancer Therapeutics Market
The lung cancer therapeutics market is projected to register a CAGR of 8.7% during the forecast period.
Prostate Cancer Diagnostics and Therapy Market
The prostate cancer diagnostics and therapy market was expected to register a CAGR of nearly 13.7% during the forecast period.
Europe Insulin Drugs Market
The Europe Insulin Drugs Market size is estimated at USD 5.95 billion in 2024, and is expected to reach USD 7.55 billion by 2029, growing at a CAGR of 4.89% during the forecast period (2024-2029).
Asthma and COPD Drugs Market
Asthma and COPD drugs market is expected to witness a CAGR of 4.6% during the forecast period.
Diabetes Care Drugs Market
The Diabetes Care Drugs Market size is estimated at USD 87.53 billion in 2024, and is expected to reach USD 104.01 billion by 2029, growing at a CAGR of 3.51% during the forecast period (2024-2029).
Antipsychotic Drugs Market
The antipsychotic drugs market is expected to register a CAGR of 5.6% over the forecast period.
Europe Diabetes Drugs Market
The Europe Diabetes Drugs Market size is estimated at USD 16.43 billion in 2024, and is expected to reach USD 20.23 billion by 2029, growing at a CAGR of 4.25% during the forecast period (2024-2029).
Oral Anti-Diabetic Drugs Market
The Oral Anti-Diabetic Drugs Market size is estimated at USD 46.82 billion in 2024, and is expected to reach USD 57.44 billion by 2029, growing at a CAGR of 4.17% during the forecast period (2024-2029).
Global Constipation Treatment Market
The constipation treatment market is expected to register a CAGR of nearly 6.9% during the forecast period of 2022-2027.
Red Biotechnology Market
The red biotechnology market is expected to register a CAGR of 6.1% over the forecast period.
Tyrosine Kinase Inhibitors Market
The Tyrosine Kinase Inhibitors Market size is estimated at USD 62.13 billion in 2024, and is expected to reach USD 92.86 billion by 2029, growing at a CAGR of 8.37% during the forecast period (2024-2029).
/chronic-lymphocytic-leukemia-market---growth,-trends,-and-forecast-(2020---2025)_CLL_MP.webp)
Chronic Lymphocytic Leukemia Market
The Chronic Lymphocytic Leukemia (CLL) Market is expected to register a CAGR of 6.01% over the forecast period.
Global Opioid Induced Constipation Market
Opioid-Induced Constipation (OIC) market studied was anticipated to grow with a CAGR of nearly 4.5% during the forecast period, 2022-2027.
Global Corticosteroids Market
The corticosteroid market is expected to witness a CAGR of 4.3% during the forecast period (2022-2027).
Netherlands Pharmaceutical Market
The Dutch pharmaceutical market is anticipated to show moderate growth with a CAGR of 5.8% during the forecast period.
Korea Pharmaceutical Market
The Korean pharmaceutical market is expected to record a CAGR of 2.5% over the forecast period.
Norway Pharmaceutical Market
The Norway pharmaceutical market it is expected to record a CAGR of 2.9% over the forecast period (2022-2027).
Italy Pharmaceutical Market
The Italy Pharmaceutical Market size is estimated at USD 37.70 billion in 2024, and is expected to reach USD 44.80 billion by 2029, growing at a CAGR of 3.51% during the forecast period (2024-2029).
Global Bronchodilators Market
The bronchodilators market studied is expected to grow with an estimated CAGR of 4.7%, over the forecast period.
Acoustic Neuroma Market
The acoustic neuroma market is expected to register a CAGR of 7.3% over the forecast period.
New Zealand Diabetes Drugs Market
The New Zealand Diabetes Drugs Market size is estimated at USD 717.24 million in 2024, and is expected to reach USD 872.63 million by 2029, growing at a CAGR of 4% during the forecast period (2024-2029).
Non-Hodgkin Lymphoma Therapeutics Market
The non-Hodgkin lymphoma therapeutics market is expected to register a CAGR of nearly 7.4% during the forecast period.
Asia-Pacific Cancer Therapy Market
The Asia-Pacific cancer therapy market is expected to register a CAGR of 10.2% over the forecast period.
Ovarian Cancer Diagnostics and Therapeutics Market
The ovarian cancer diagnostics and therapeutics market is projected to register a CAGR of 9.5% during the forecast period.
Preventive Vaccines Market
The Preventive Vaccines Market size is estimated at USD 89.51 billion in 2024, and is expected to reach USD 96.04 billion by 2029, growing at a CAGR of 1.42% during the forecast period (2024-2029).
Europe Cancer Therapeutics Market
The Europe Cancer Therapeutics Market size is estimated at USD 58.32 billion in 2024, and is expected to reach USD 75.79 billion by 2029, growing at a CAGR of 5.38% during the forecast period (2024-2029).
Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
The Europe Dipeptide Peptidase 4 Inhibitors Market size is estimated at USD 1.79 billion in 2024, and is expected to reach USD 2.04 billion by 2029, growing at a CAGR of 2.73% during the forecast period (2024-2029).
Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
The Dipeptide Peptidase 4 Inhibitors Market size is estimated at USD 11.59 billion in 2024, and is expected to reach USD 13.30 billion by 2029, growing at a CAGR of 2.78% during the forecast period (2024-2029).
Asia-Pacific Glucagon-like Peptide-1 (GLP-1) Agonists Market
The Asia-Pacific Glucagon-like Peptide-1 Agonists Market size is estimated at USD 0.9 billion in 2024, and is expected to reach USD 1.17 billion by 2029, growing at a CAGR of 5.38% during the forecast period (2024-2029).
Europe Glucagon-Like Peptide-1 (GLP-1) Agonists Market
The Europe Glucagon-Like Peptide-1 Agonists Market size is estimated at USD 3.94 billion in 2024, and is expected to reach USD 5.25 billion by 2029, growing at a CAGR of 5.90% during the forecast period (2024-2029).
North America Glucagon-like Peptide-1 Agonists Market
The North America Glucagon-like Peptide-1 Agonists Market size is estimated at USD 6.94 billion in 2024, and is expected to decline to USD 6.68 billion by 2029.
Glucagon-like Peptide-1 (GLP-1) Agonists Market
The Glucagon-like Peptide-1 Agonists Market size is estimated at USD 11.99 billion in 2024, and is expected to reach USD 12.63 billion by 2029, growing at a CAGR of 1.12% during the forecast period (2024-2029).
Asia-Pacific Diabetes Care Drugs Market
The Asia-Pacific Diabetes Care Drugs Market size is estimated at USD 24.99 billion in 2024, and is expected to reach USD 28.70 billion by 2029, growing at a CAGR of 2.81% during the forecast period (2024-2029).
North America Sodium-Dependent Glucose Co-Transporter 2 (Sglt2) Market
The North America Sodium-Dependent Glucose Co-Transporter 2 Market size is estimated at USD 7.39 billion in 2024, and is expected to reach USD 10.99 billion by 2029, growing at a CAGR of 8.67% during the forecast period (2024-2029).
Asia-Pacific Sodium-dependent Glucose Cotransporter 2 (SGLT-2) Market
The Asia-Pacific Sodium-dependent Glucose Cotransporter 2 Market size is estimated at USD 1.82 billion in 2024, and is expected to reach USD 2.72 billion by 2029, growing at a CAGR of 8.35% during the forecast period (2024-2029).
Europe Sodium-dependent Glucose Cotransporter 2 Market
The Europe Sodium-dependent Glucose Cotransporter 2 Market size is estimated at USD 1.30 billion in 2024, and is expected to reach USD 2.02 billion by 2029, growing at a CAGR of 9.10% during the forecast period (2024-2029).
Latin America Diabetes Care Drugs Market
The Latin America Diabetes Care Drugs Market size is estimated at USD 4.71 billion in 2024, and is expected to reach USD 5.58 billion by 2029, growing at a CAGR of 3.48% during the forecast period (2024-2029).
Global Bipolar Disorder Market
The bipolar disorder market is expected to register a CAGR of nearly 2.5% during the forecast period.
Global Asthma and COPD Devices Market
The asthma and COPD devices market is projected to register a CAGR of 5.2% during the forecast period (2022-2027).
Global Pulmonary Drugs Market
The pulmonary drugs market is expected to register a CAGR of 5.4% over the forecast period (2022-2027).
Nasal Drug Delivery Market
The nasal drug delivery market will show a rapid growth owing to the increasing patient preference for nasal drug delivery as a result of easy administration and better efficacy, growing adoption of self-administration practices and the rise in demand for home healthcare devices.
Tourette Syndrome Treatment Market
The tourette syndrome (TS) treatment market is expected to register a CAGR of 10.4% over the forecast period.
Global Hypertrophic Cardiomyopathy Therapeutics Market
The Hypertrophic Cardiomyopathy Therapeutics Market is expected to grow at a CAGR of 1.8% over the forecast period (2022-2027).
Antithrombotic Drugs Market
The antithrombotic drug market is projected to register a CAGR of 7.5% during the forecast period.
Global Geriatric Medicines Market
The geriatric medicines market is expected to register a CAGR of 6.5% over the forecast period (2022-2027).
Coronary Artery Disease Therapeutics Market
The Coronary Artery Disease Therapeutics Market is expected to register a CAGR of 7.7% during the forecast period.
Immune Checkpoint Inhibitors Market
The immune checkpoint inhibitors market is anticipated to register a CAGR of 18% during the forecast period.
Global Atherosclerosis Drugs Market
The Atherosclerosis Drugs Market is projected to register a CAGR of 2.2% during the forecast period (2022-2027).
Global Hyperlipidemia Drugs Market
The hyperlipidemia drugs market is expected to register a CAGR of 2.3% during the forecast period.
Finland Pharmaceutical Market
The Finland pharmaceutical market is anticipated to register a CAGR of 3.9% during the forecast period.
Europe Insulin Drugs And Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market
The Europe Insulin Drugs And Glucagon-Like Peptide 1 Receptor Agonist Market size is estimated at USD 9.62 billion in 2024, and is expected to reach USD 12.05 billion by 2029, growing at a CAGR of 4.61% during the forecast period (2024-2029).
Non-Small Cell Lung Cancer (NSCLC) Market
The non-small cell lung cancer (NSCLC) market is expected to register a CAGR of 9.5% during the forecast period.
Androgen Deprivation Therapy Market
The Androgen Deprivation Therapy Market is expected to register a significant CAGR of 5.2% during the study period.
Rare Disease Treatment Market
The Rare Disease Treatment Market size is estimated at USD 216.65 billion in 2024, and is expected to reach USD 380.62 billion by 2029, growing at a CAGR of 11.93% during the forecast period (2024-2029).
Egypt Diabetes Drugs Market
The Egypt Diabetes Drugs Market size is estimated at USD 414.66 million in 2024, and is expected to reach USD 480.70 million by 2029, growing at a CAGR of 3% during the forecast period (2024-2029).
Saudi Arabia Diabetes Drugs Market
The Saudi Arabia Diabetes Drugs Market size is estimated at USD 1.87 billion in 2024, and is expected to reach USD 2.89 billion by 2029, growing at a CAGR of 9% during the forecast period (2024-2029).
Mexico Diabetes Drugs Market
The Mexico Diabetes Drugs Market size is estimated at USD 2.04 billion in 2024, and is expected to reach USD 2.39 billion by 2029, growing at a CAGR of 3.30% during the forecast period (2024-2029).
Vietnam Diabetes Care Drugs Market
The Vietnam Diabetes Care Drugs Market size is estimated at USD 208.45 million in 2024, and is expected to reach USD 249.97 million by 2029, growing at a CAGR of 3.70% during the forecast period (2024-2029).
India Diabetes Care Drugs Market
The India Diabetes Care Drugs Market size is estimated at USD 1.7 billion in 2024, and is expected to reach USD 2.01 billion by 2029, growing at a CAGR of 3.5% during the forecast period (2024-2029).
Russia Diabetes Drugs Market
The Russia Diabetes Drugs Market size is estimated at USD 1.04 billion in 2024, and is expected to reach USD 1.31 billion by 2029, growing at a CAGR of 4.5% during the forecast period (2024-2029).
Global Lipid Regulators Market
The lipid regulators market is expected to register a CAGR of 5.1% over the forecast period.
MEA Cancer Vaccines Market
The Middle East and Africa cancer vaccine market is expected to register a CAGR of 9.6% during the forecast period.
Europe Bladder Cancer Therapeutics and Diagnostics Market
Europe's bladder cancer therapeutics and diagnostics market is projected to register a CAGR of 5% over the forecast period.
South America Bladder Cancer Therapeutics and Diagnostics Market
The South America Bladder Cancer Therapeutics and Diagnostics Market is projected to record a CAGR of 3.0% over the forecast period.
MEA Sodium-dependent Glucose Co-transporter 2 Inhibitors Market
The MEA Sodium-dependent Glucose Co-transporter 2 Inhibitors Market size is estimated at USD 165.5 million in 2024, and is expected to reach USD 256.40 million by 2029, growing at a CAGR of 9.15% during the forecast period (2024-2029).
Hyperkalemia Treatment Market
The hyperkalemia treatment market is poised to register a CAGR of 16.79% over the forecast period.
Human Respiratory Syncytial Virus Treatment Market
The human respiratory syncytial virus (RSV) treatment market is expected to register a CAGR of 10% during the forecast period.
Global Gastroparesis Drug Market
The Gastroparesis Drug Market is expected to register a CAGR of 4.5% over the forecast period.
Enzyme Inhibitors Market
The enzyme inhibitors market is projected to register a CAGR of 3.95% during the forecast period.
DNA Repair Drugs Market
The DNA repair drugs market is expected to register a CAGR of nearly 13% over the forecast period.
Global Targeted Cancer Therapy Market
The targeted cancer therapy market is projected to record a CAGR of 7.1% during the forecast period.
Global Pericarditis Drugs Market
The pericarditis drugs market is expected to register a CAGR of 5.2% over the forecast period (2022-2027).
Global Treatment-Resistant Depression Market
The Treatment- Resistant Depression market is projected to register a CAGR of 4% during the forecast period.
Oman Diabetes Drugs Market
The Oman Diabetes Drugs Market size is estimated at USD 212.26 million in 2024, and is expected to reach USD 292.31 million by 2029, growing at a CAGR of 6.61% during the forecast period (2024-2029).
South Africa Diabetes Drugs Market
The South Africa Diabetes Drugs Market size is estimated at USD 340.72 million in 2024, and is expected to reach USD 384.74 million by 2029, growing at a CAGR of 2.46% during the forecast period (2024-2029).
Indonesia Diabetes Care Drugs Market
The Indonesia Diabetes Care Drugs Market size is estimated at USD 301.55 million in 2024, and is expected to reach USD 370.43 million by 2029, growing at a CAGR of 4.20% during the forecast period (2024-2029).
Malaysia Diabetes Care Drugs Market
The Malaysia Diabetes Care Drugs Market size is estimated at USD 389.13 million in 2024, and is expected to reach USD 423.21 million by 2029, growing at a CAGR of 3.10% during the forecast period (2024-2029).
China Diabetes Care Drugs Market
The China Diabetes Care Drugs Market size is estimated at USD 12.34 billion in 2024, and is expected to reach USD 14.10 billion by 2029, growing at a CAGR of 2.70% during the forecast period (2024-2029).
Next-Generation Antibody Therapeutics Market
Over the next few years, the market for next-generation antibody therapeutics is expected to register a CAGR of 12.1%.
Latin America Oral Anti-Diabetic Drug Market
The Latin America Oral Anti-Diabetic Drug Market size is estimated at USD 3.25 billion in 2024, and is expected to reach USD 3.86 billion by 2029, growing at a CAGR of 3.5% during the forecast period (2024-2029).
Hairy Cell Leukemia Market
The hairy cell leukemia market is expected to grow at a CAGR of 5.0% during the forecast period.
Asia-Pacific Bladder Cancer Therapeutics and Diagnostics Market
Asia-Pacific Bladder Cancer Therapeutics and Diagnostics market is expected to register a CAGR of 5% during the forecast period, owing to increasing burden of bladder cancer and new diagnosis & treatments coming up in the market.
North America Cancer Therapy Market
The North America cancer therapy market is estimated to grow at a CAGR of 8.1% during the forecasted period.
Latin America Bladder Cancer Therapeutics & Diagnostics Market
Based on the data from the International Agency for Research on Cancer, bladder cancer is the 6th most commonly diagnosed cancer of males and the 9th leading cause of cancer deaths worldwide.
APAC Ovarian Cancer Diagnostics & Therapeutics Market Size
The Asia-Pacific ovarian cancer diagnostics and therapeutics market is expected to register a CAGR of 15.1% during the forecast period.
South America Ovarian Cancer Diagnostics and Therapeutics Market
The rising incidences of ovarian cancer are one of the primary drivers for the market.
United Arab Emirates Drug Delivery Devices Market
The UAE drug delivery devices market is poised to register a CAGR of 20% over the forecast period.
North America Bladder Cancer Therapeutics and Diagnostics Market
North America bladder cancer therapeutics and diagnostics market is expected to register a CAGR of 5% over the forecast period.
MEA Bladder Cancer Therapeutics & Diagnostics Market
The bladder cancer therapeutics and diagnostics market will witness rapid growth due to the increasing awareness about bladder diseases and available therapies, along with growing innovation in drug development.
Europe Novel Drug Delivery System (NDDS) Market
European novel drug delivery system market primarily driven by technological advancements promoting the development of NDDS and the rising need for controlled release of drugs.
Asia-Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
The Asia-Pacific Dipeptide Peptidase 4 Inhibitors Market size is estimated at USD 4.30 billion in 2024, and is expected to reach USD 5.18 billion by 2029, growing at a CAGR of 3.80% during the forecast period (2024-2029).
Europe Biguanide Market
The Europe Biguanide Market size is estimated at USD 1.25 billion in 2024, and is expected to reach USD 1.33 billion by 2029, growing at a CAGR of 1.27% during the forecast period (2024-2029).
Global Urothelial Cancer Drugs Market
The urothelial cancer drugs market studied is projected to register a CAGR of 15.5% over the forecast period.
Dilated Cardiomyopathy Therapeutic Market
The Dilated Cardiomyopathy Therapeutic Market is projected to register a CAGR of 3.6% during the forecast period.
Lipid Disorder Treatment Market
The major factors attributing to the growth of the lipid disorder treatment market are the growing prevalence of lifestyle diseases like obesity and increasing smoking and alcohol consumption.
H1N1 Vaccines Market
The H1N1 Vaccines Market is expected to register a CAGR of 5.2% during the forecast period.
Global HER-2 Negative Breast Cancer Market
The Global HER-2 Negative Breast Cancer Market size is estimated at USD 15.03 billion in 2024, and is expected to reach USD 23.32 billion by 2029, growing at a CAGR of 9.17% during the forecast period (2024-2029).
Incretin-based Drugs Market
The incretin-based drugs market is expected to register a CAGR of 5.2% during the forecast period.
Endocrinology Drugs Market
The endocrinology drugs market is expected to register a CAGR of 6.8% over the forecast period.
Germany Diabetes Drugs Market
The Germany Diabetes Drugs Market size is estimated at USD 4.06 billion in 2024, and is expected to reach USD 4.81 billion by 2029, growing at a CAGR of 3.47% during the forecast period (2024-2029).
Italy Diabetes Drugs Market
The Italy Diabetes Drugs Market size is estimated at USD 1.12 billion in 2024, and is expected to reach USD 1.31 billion by 2029, growing at a CAGR of 3% during the forecast period (2024-2029).
United Kingdom (UK) Diabetes Drugs Market
The United Kingdom Diabetes Drugs Market size is estimated at USD 1.06 billion in 2024, and is expected to reach USD 1.24 billion by 2029, growing at a CAGR of 3.05% during the forecast period (2024-2029).
France Diabetes Drugs Market
The France Diabetes Drugs Market size is estimated at USD 1.42 billion in 2024, and is expected to reach USD 1.67 billion by 2029, growing at a CAGR of 3.22% during the forecast period (2024-2029).
Spain Diabetes Care Drugs Market
The Spain Diabetes Care Drugs Market size is estimated at USD 1.21 billion in 2024, and is expected to reach USD 1.52 billion by 2029, growing at a CAGR of 4.5% during the forecast period (2024-2029).
Brazil Diabetes Drugs Market
The Brazil Diabetes Drugs Market size is estimated at USD 1.66 billion in 2024, and is expected to reach USD 2.02 billion by 2029, growing at a CAGR of 4.10% during the forecast period (2024-2029).
Australia Diabetes Care Drugs Market
The Australia Diabetes Care Drugs Market size is estimated at USD 815.19 million in 2024, and is expected to reach USD 972.88 million by 2029, growing at a CAGR of 3.60% during the forecast period (2024-2029).
Latin America Glucagon-like Peptide-1 (GLP-1) Agonists Market
The Latin America Glucagon-like Peptide-1 Agonists Market size is estimated at USD 203.89 million in 2024, and is expected to reach USD 266.48 million by 2029, growing at a CAGR of 5.5% during the forecast period (2024-2029).
Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
The Latin America Dipeptide Peptidase 4 Inhibitors Market size is estimated at USD 754.60 million in 2024, and is expected to reach USD 931.40 million by 2029, growing at a CAGR of 4.30% during the forecast period (2024-2029).
Latin America Sodium-Glucose Cotransport-2 (SGLT-2) Inhibitor Market
The Latin America Sodium-Glucose Cotransport-2 (SGLT-2) Inhibitor Market size is estimated at USD 0.3 billion in current year, and is expected to reach USD 0.5 billion by forecast period, growing at a CAGR of 9% during the forecast period.
Other Reports Covering AstraZeneca
Biotechnology
- Biopharmaceuticals Market
- Blood Preparation Market
- Drug Discovery Market
- Global Cytokine Market
- Global Monoclonal Antibodies Market
- Global Neurology Clinical Trials Market
- Global Oncology Clinical Trials Market
- Global Viral Vector Manufacturing Market
- Next-Generation Antibody Therapeutics Market
- Pharmaceutical Manufacturing Market
- Red Biotechnology Market
Device Drug Combination
- Alzheimer's Disease Diagnostics and Therapeutics Market
- Androgen Deprivation Therapy Market
- APAC Ovarian Cancer Diagnostics & Therapeutics Market Size
- Asia-Pacific Bladder Cancer Therapeutics and Diagnostics Market
- Australia Diabetes Drugs and Devices Market
- Canada Diabetes Care Drugs And Devices Market
- Canada Diabetes Care Drugs And Devices Market
- China Diabetes Drugs And Devices Market
- Egypt Diabetes Drugs and Devices Market
- Europe Bladder Cancer Therapeutics and Diagnostics Market
- Europe Ovarian Cancer Diagnostics and Therapeutics Market
- Gastroesophageal Reflux Disease Market
- Germany Diabetes Drugs and Devices Market
- Global Advanced Drug Delivery Systems Market
- Global Auto-Injectors Market
- Global Pancreatic Cancer Therapeutics and Diagnostics Market
- India Diabetes Drugs and Devices Market
- Indonesia Oral Anti-Diabetic Drug Market
- Iran Diabetes Drugs and Devices Market
- Japan Diabetes Drugs And Devices Market
- MEA Bladder Cancer Therapeutics & Diagnostics Market
- Mexico Diabetes Drugs and Devices Market
- Middle East & Africa Ovarian Cancer Diagnostics And Therapeutics Market
- Nasal Drug Delivery Market
- New Zealand Insulin Drugs and Devices Market
- North America Bladder Cancer Therapeutics and Diagnostics Market
- Oman Diabetes Drugs And Devices Market
- Ovarian Cancer Diagnostics and Therapeutics Market
- Philippines Diabetes Drugs and Devices Market
- Philippines Oral Anti-Diabetic Drug Market
- Prostate Cancer Diagnostics and Therapy Market
- Prostate Health Market
- Russia Diabetes Drugs and Devices Market
- South Africa Diabetes Drugs and Devices Market
- South Africa Oral Antidiabetic Drug Market
- South America Bladder Cancer Therapeutics and Diagnostics Market
- South America Ovarian Cancer Diagnostics and Therapeutics Market
- South Korea Diabetes Drugs and Devices Market
- Spain Diabetes Drugs and Devices Market
- Thailand Diabetes Drugs And Devices Market
- Thailand Oral Antidiabetic Drug Market
- Type 2 Diabetes Drugs And Devices Market
- United Arab Emirates Drug Delivery Devices Market
- US Diabetes Drugs And Devices Market
- Vietnam Diabetes Drugs and Devices Market
- Vietnam Insulin Drug And Delivery Device Market
- Vietnam Oral Anti-Diabetic Drug Market
Medical Devices
- Brazil Oral Anti-Diabetic Drug Market
- Europe Novel Drug Delivery System (NDDS) Market
- France Oral Anti-Diabetic Drug Market
- Global Asthma and COPD Devices Market
- Global Minimal Residual Disease Market
- Heart Attack Diagnostics Market
- India Insulin Drug And Delivery Device Market
- North America Advanced Drug Delivery Systems Market
- North America Novel Drug Delivery Systems (NDDS) Market
- Novel Drug Delivery Systems (NDDS) Market
- Pulmonary Drug Delivery Systems Market
- South Korea Oral Anti-Diabetic Drug Market
- Sustained Release Excipients Market
Pharmaceuticals
- Immunotherapy Drugs Market
- Preventive Vaccines Market
- Acoustic Neuroma Market
- Anti Inflammatory Drugs Market
- Anti-Viral Therapeutics Market
- Antibody-drug Conjugates Market
- Antidepressant Market
- Antihistamine Market
- Antipsychotic Drugs Market
- Antithrombotic Drugs Market
- Asia-Pacific Cancer Therapy Market
- Asia-Pacific Cancer Vaccines Market
- Asia-Pacific Diabetes Care Drugs Market
- Asia-Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
- Asia-Pacific Glucagon-like Peptide-1 (GLP-1) Agonists Market
- Asia-Pacific Oral Anti-Diabetic Drug Market
- Asia-Pacific Sodium-dependent Glucose Cotransporter 2 (SGLT-2) Market
- Asthma and COPD Drugs Market
- Australia Diabetes Care Drugs Market
- Australia Pharmaceuticals Market
- Belgium Pharmaceutical Market
- Biologics Market
- Blood Disorder Therapeutics Market
- Brain Tumor Therapeutics Market
- Brazil Diabetes Drugs Market
- Brazil Oral Anti-Diabetic Drug Market
- Breast Cancer Therapy Market
- Cancer Immunotherapy Market
- Cancer Vaccines Market
- Castrate Resistant Prostate Cancer Therapeutics Market
- Central Nervous System Therapeutics Market
- China Diabetes Care Drugs Market
- Chronic Lymphocytic Leukemia Market
- Coronary Artery Disease Therapeutics Market
- Cough Hypersensitivity Syndrome Treatment Market
- Cough Remedies Market
- Cystic Fibrosis (CF) Therapeutics Market
- Dementia Drugs Market
- Dextromethorphan Market
- Diabetes Care Drugs Market
- Dilated Cardiomyopathy Therapeutic Market
- Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
- DNA Repair Drugs Market
- Egypt Diabetes Drugs Market
- Endocrinology Drugs Market
- Esomeprazole Market
- Europe Biguanide Market
- Europe Cancer Therapeutics Market
- Europe Diabetes Drugs Market
- Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
- Europe Glucagon-Like Peptide-1 (GLP-1) Agonists Market
- Europe Insulin Drugs And Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market
- Europe Insulin Drugs Market
- Europe Monoclonal Antibodies Market
- Europe Oral Anti-Diabetic Drug Market
- Europe Sodium-dependent Glucose Cotransporter 2 Market
- Expectorant Drugs Market
- Finland Pharmaceutical Market
- France Diabetes Drugs Market
- Frontotemporal Disorders Treatment Market
- Gastric Cancer Therapy Market
- Gastrointestinal Therapeutics Market
- Germany Diabetes Drugs Market
- Germany OTC Drug Market
- Global Anti-hypertensive Drugs Market
- Global Anxiety Disorders and Depression Treatment Market
- Global Atherosclerosis Drugs Market
- Global Autoimmune Treatment Market
- Global Bipolar Disorder Market
- Global Bronchitis Treatment Market
- Global Bronchodilators Market
- Global Cancer Therapy Market
- Global Constipation Treatment Market
- Global Corticosteroids Market
- Global Endometrial Cancer Market
- Global Gastroparesis Drug Market
- Global Geriatric Medicines Market
- Global Hematologic Malignancies Treatment Market
- Global HER-2 Negative Breast Cancer Market
- Global Hyperlipidemia Drugs Market
- Global Hypertrophic Cardiomyopathy Therapeutics Market
- Global Interleukin Inhibitors Market
- Global Leukemia Therapeutics Market
- Global Lipid Regulators Market
- Global Metastatic Cancer Treatment Market
- Global Metastatic Melanoma Drugs Market
- Global Migraine Therapeutics Market
- Global Opioid Induced Constipation Market
- Global Orphan Drugs Market
- Global Parkinson's Disease Drugs Market
- Global Pediatric Vaccines Market
- Global Pericarditis Drugs Market
- Global Polycystic Ovarian Syndrome Treatment Market
- Global Psoriasis Drugs Market
- Global Pulmonary Drugs Market
- Global Schizophrenia Drugs Market
- Global Targeted Cancer Therapy Market
- Global Treatment-Resistant Depression Market
- Global Urothelial Cancer Drugs Market
- Global Waldenstrom's Macroglobulinemia (WM) Treatment Market
- Glucagon-like Peptide-1 (GLP-1) Agonists Market
- Gonorrhea Therapeutics Market
- Gram-positive Bacterial Infections Market
- Gynecology Drugs Market
- H1N1 Vaccines Market
- Hairy Cell Leukemia Market
- Head and Neck Cancer Therapeutics Market
- Human Papillomavirus Vaccine Market
- Human Respiratory Syncytial Virus Treatment Market
- Hyperkalemia Treatment Market
- Immune Checkpoint Inhibitors Market
- Incretin-based Drugs Market
- India Diabetes Care Drugs Market
- India Oral Anti-Diabetic Drug Market
- Indonesia Diabetes Care Drugs Market
- Influenza Vaccine Market
- Iran Diabetes Care Drugs Market
- Italy Diabetes Drugs Market
- Italy Oral Anti-Diabetic Drug Market
- Japan Diabetes Drugs Market
- Japan Oral Anti-Diabetic Drug Market
- Korea Pharmaceutical Market
- Latin America Bladder Cancer Therapeutics & Diagnostics Market
- Latin America Diabetes Care Drugs Market
- Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
- Latin America Glucagon-like Peptide-1 (GLP-1) Agonists Market
- Latin America Oral Anti-Diabetic Drug Market
- Latin America Sodium-Glucose Cotransport-2 (SGLT-2) Inhibitor Market
- Lipid Disorder Treatment Market
- Liver Cancer Therapeutics Market
- Lung Cancer Therapeutics Market
- Malaysia Diabetes Care Drugs Market
- Malaysia Oral Anti-Diabetic Drug Market
- MEA Cancer Vaccines Market
- MEA Sodium-dependent Glucose Co-transporter 2 Inhibitors Market
- Menopausal Hot Flashes Market
- Mexico Diabetes Drugs Market
- Mexico Oral Anti-Diabetic Drug Market
- Middle East and Africa Diabetes Drugs Market
- Middle East And Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
- Middle East And Africa Glucagon-like Peptide-1 (GLP-1) Agonists Market
- mRNA Vaccines and Therapeutics Market
- Neurological Disorder Drugs Market
- Neuromyelitis Optica Spectrum Disorder Market
- New Zealand Diabetes Drugs Market
- New Zealand Oral Anti-Diabetic Drug Market
- Non-Hodgkin Lymphoma Therapeutics Market
- Non-Small Cell Lung Cancer (NSCLC) Market
- North America Cancer Therapy Market
- North America Diabetes Drugs Market
- North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
- North America Glucagon-like Peptide-1 Agonists Market
- North America Oral Anti-Diabetic Drug Market
- North America Sodium-Dependent Glucose Co-Transporter 2 (Sglt2) Market
- Norway Pharmaceutical Market
- Oman Diabetes Drugs Market
- Omeprazole and Antihistamine Market
- Oral Anti-Diabetic Drugs Market
- PD-1 And PD-L1 Inhibitors Market
- Pediatric Respiratory Disease Therapeutics Market
- Pelvic Inflammatory Disease Therapeutics Market
- Peptide Therapeutics Market
- Philippines Diabetes Care Drugs Market
- Polypill Products Market
- Precision Medicine Market
- Proton Pump Inhibitors Market
- Pseudomonas Aeruginosa Infection Treatment Market
- Rare Disease Treatment Market
- Russia Diabetes Drugs Market
- Saudi Arabia Diabetes Drugs Market
- Sodium-dependent Glucose Co-transporter 2 (SGLT 2) Market
- Solid Tumor Therapeutics Market
- South Africa Diabetes Drugs Market
- South Korea Diabetes Drugs Market
- Spain Diabetes Care Drugs Market
- Spain Over-the-counter (OTC) Drugs Market
- Systemic Lupus Erythematosus Market
- Thailand Diabetes Care Drugs Market
- Therapeutic Vaccine Market
- Thrombosis Drugs Market
- Tourette Syndrome Treatment Market
- Tyrosine Kinase Inhibitors Market
- United Kingdom (UK) Diabetes Drugs Market
- Unresectable Hepatocellular Carcinoma Market
- Urinary Tract Infection Therapeutics Market
- US Diabetes Care Drugs Market
- Vietnam Diabetes Care Drugs Market
Industries AstraZeneca Operates Within:
Oncology Drugs Companies
- Europe Oncology Drugs Companies
- Middle East and Africa Oncology Drugs Companies
- South America Oncology Drugs Companies
- Asia Oncology Drugs Companies
- Europe Oncology Drugs Companies
- Middle East and Africa Oncology Drugs Companies
- North America Oncology Drugs Companies
- South America Oncology Drugs Companies
Pharmaceuticals Companies
- Europe Pharmaceuticals Companies
- Middle East and Africa Pharmaceuticals Companies
- South America Pharmaceuticals Companies
- Asia Pharmaceuticals Companies
- Europe Pharmaceuticals Companies
- Middle East and Africa Pharmaceuticals Companies
- North America Pharmaceuticals Companies
- South America Pharmaceuticals Companies
- Brazil Pharmaceuticals Companies
- France Pharmaceuticals Companies
- Brazil Pharmaceuticals Companies
- France Pharmaceuticals Companies
- Saudi Arabia Pharmaceuticals Companies
- US Pharmaceuticals Companies
